Acosta RK, Willkom M, Andreatta K, Liu H, et al. Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-Existing NRTI Resistance. J Acquir Immune Defic Syndr 2020 Jul 21. doi: 10.1097/QAI.0000000000002454.
PMID: 32701823